390 related articles for article (PubMed ID: 37465682)
81. Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants.
Miyamoto S; Arashiro T; Adachi Y; Moriyama S; Kinoshita H; Kanno T; Saito S; Katano H; Iida S; Ainai A; Kotaki R; Yamada S; Kuroda Y; Yamamoto T; Ishijima K; Park ES; Inoue Y; Kaku Y; Tobiume M; Iwata-Yoshikawa N; Shiwa-Sudo N; Tokunaga K; Ozono S; Hemmi T; Ueno A; Kishida N; Watanabe S; Nojima K; Seki Y; Mizukami T; Hasegawa H; Ebihara H; Maeda K; Fukushi S; Takahashi Y; Suzuki T
Med; 2022 Apr; 3(4):249-261.e4. PubMed ID: 35261995
[TBL] [Abstract][Full Text] [Related]
82. Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees.
Andreano E; Paciello I; Marchese S; Donnici L; Pierleoni G; Piccini G; Manganaro N; Pantano E; Abbiento V; Pileri P; Benincasa L; Giglioli G; Leonardi M; Maes P; De Santi C; Sala C; Montomoli E; De Francesco R; Rappuoli R
Nat Commun; 2022 Jun; 13(1):3375. PubMed ID: 35697673
[TBL] [Abstract][Full Text] [Related]
83. Maternal Antibody Response and Transplacental Transfer Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection or Vaccination in Pregnancy.
Otero S; Miller ES; Sunderraj A; Shanes ED; Sakowicz A; Goldstein JA; Mithal LB
Clin Infect Dis; 2023 Jan; 76(2):220-228. PubMed ID: 36348510
[TBL] [Abstract][Full Text] [Related]
84. SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates.
Murphy EA; Guzman-Cardozo C; Sukhu AC; Parks DJ; Prabhu M; Mohammed I; Jurkiewicz M; Ketas TJ; Singh S; Canis M; Bednarski E; Hollingsworth A; Thompson EM; Eng D; Bieniasz PD; Riley LE; Hatziioannou T; Yang YJ
Nat Commun; 2023 Aug; 14(1):4598. PubMed ID: 37563124
[TBL] [Abstract][Full Text] [Related]
85. SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies.
Lusvarghi S; Pollett SD; Neerukonda SN; Wang W; Wang R; Vassell R; Epsi NJ; Fries AC; Agan BK; Lindholm DA; Colombo CJ; Mody R; Ewers EC; Lalani T; Ganesan A; Goguet E; Hollis-Perry M; Coggins SA; Simons MP; Katzelnick LC; Wang G; Tribble DR; Bentley L; Eakin AE; Broder CC; Erlandson KJ; Laing ED; Burgess TH; Mitre E; Weiss CD
Sci Transl Med; 2022 May; 14(645):eabn8543. PubMed ID: 35380448
[TBL] [Abstract][Full Text] [Related]
86. Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines.
Lu L; Chen LL; Zhang RR; Tsang OT; Chan JM; Tam AR; Leung WS; Chik TS; Lau DP; Choi CY; Fong CH; Cai JP; Tsoi HW; Choi CY; Zhang X; Abdullah SMU; Chan BP; Chan KH; Yuen KY; Hung IF; To KK
EBioMedicine; 2022 May; 79():103986. PubMed ID: 35398786
[TBL] [Abstract][Full Text] [Related]
87. Serologic responses to COVID-19 vaccination in children with history of multisystem inflammatory syndrome (MIS-C).
Perez MA; Hsiao HM; Chen X; Kunkel A; Baida N; Hussaini L; Lu AT; Kao CM; Laham FR; Hunstad DA; Beltran Y; Hammett TA; Godfred-Cato S; Chahroudi A; Anderson EJ; Belay E; Rostad CA
Vaccine; 2023 Apr; 41(17):2743-2748. PubMed ID: 36964000
[TBL] [Abstract][Full Text] [Related]
88. Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines.
Bartsch YC; Tong X; Kang J; Avendaño MJ; Serrano EF; García-Salum T; Pardo-Roa C; Riquelme A; Cai Y; Renzi I; Stewart-Jones G; Chen B; Medina RA; Alter G
Sci Transl Med; 2022 Apr; 14(642):eabn9243. PubMed ID: 35289637
[TBL] [Abstract][Full Text] [Related]
89. Kinetics of adaptive immune responses after administering mRNA-Based COVID-19 vaccination in individuals with and without prior SARS-CoV-2 infections.
Yoon SW; Widyasari K; Jang J; Lee S; Kang T; Kim S
BMC Infect Dis; 2023 Oct; 23(1):732. PubMed ID: 37891503
[TBL] [Abstract][Full Text] [Related]
90. Long-term analysis of humoral responses and spike-specific T cell memory to Omicron variants after different COVID-19 vaccine regimens.
Ho CL; Yen LC; Huang HW; Lu CC; Hung YJ; Liao CL; Hung CM; Chiu KC
Front Immunol; 2024; 15():1340645. PubMed ID: 38533494
[TBL] [Abstract][Full Text] [Related]
91. Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm's COVID-19 Vaccines.
Adjobimey T; Meyer J; Sollberg L; Bawolt M; Berens C; Kovačević P; Trudić A; Parcina M; Hoerauf A
Front Immunol; 2022; 13():917905. PubMed ID: 35799790
[TBL] [Abstract][Full Text] [Related]
92. Determining the Time of Booster Dose Based on the Half-Life and Neutralization Titers against SARS-CoV-2 Variants of Concern in Fully Vaccinated Individuals.
Dai YC; Lin YC; Ching LL; Tsai JJ; Ishikawa K; Tsai WY; Chen JJ; Nerurkar VR; Wang WK
Microbiol Spectr; 2023 Aug; 11(4):e0408122. PubMed ID: 37428104
[TBL] [Abstract][Full Text] [Related]
93. SARS-CoV-2 Antibody Profiles in Maternal Serum and Breast Milk Following mRNA COVID-19 Vaccination: A Longitudinal Prospective Observational Cohort Study.
Hsiao HM; DiMaggio LS; Perez MA; Chen X; Stephens K; Gibson T; Anderson EJ; Rostad CA
Vaccines (Basel); 2023 Oct; 11(11):. PubMed ID: 38005975
[TBL] [Abstract][Full Text] [Related]
94. Maternal antibody transfer rate of vaccination against SARS-CoV-2 before or during early pregnancy and its protective effectiveness on offspring.
Liu S; Wang P; Shi X; Weng T; Zhong J; Zhang X; Qu J; Chen L; Xu Q; Meng X; Xiong H; Wu D; Fang D; Peng B; Zhang D
J Med Virol; 2023 Oct; 95(10):e29125. PubMed ID: 37800607
[TBL] [Abstract][Full Text] [Related]
95. Infection and Vaccine Induced Spike Antibody Responses Against SARS-CoV-2 Variants of Concern in COVID-19-Naïve Children and Adults.
Pillay A; Yeola A; Tea F; Denkova M; Houston S; Burrell R; Merheb V; Lee FXZ; Lopez JA; Moran L; Jadhav A; Sterling K; Lai CL; Vitagliano TL; Aggarwal A; Catchpoole D; Wood N; Phan TG; Nanan R; Hsu P; Turville SG; Britton PN; Brilot F
J Clin Immunol; 2023 Nov; 43(8):1706-1723. PubMed ID: 37405544
[TBL] [Abstract][Full Text] [Related]
96. Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concern.
McNamara RP; Maron JS; Boucau J; Roy V; Webb NE; Bertera HL; Barczak AK; Positives Study Staff T; Franko N; Logue JK; Kemp M; Li JZ; Zhou L; Hsieh CL; McLellan JS; Siedner MJ; Seaman MS; Lemieux JE; Chu HY; Alter G
mBio; 2023 Aug; 14(4):e0090223. PubMed ID: 37535402
[TBL] [Abstract][Full Text] [Related]
97. Dynamics of temporal immune responses in nonhuman primates and humans immunized with COVID-19 vaccines.
Ravindran R; Kang H; McReynolds C; Sanghar GK; Chang WLW; Ramasamy S; Kolloli A; Kumar R; Subbian S; Hammock BD; Hartigan-O'Connor DJ; Ikram A; Haczku A; Khan IH
PLoS One; 2023; 18(10):e0287377. PubMed ID: 37856429
[TBL] [Abstract][Full Text] [Related]
98. Potency of BNT162b2 and mRNA-1273 vaccine-induced neutralizing antibodies against severe acute respiratory syndrome-CoV-2 variants of concern: A systematic review of in vitro studies.
Noori M; Nejadghaderi SA; Arshi S; Carson-Chahhoud K; Ansarin K; Kolahi AA; Safiri S
Rev Med Virol; 2022 Mar; 32(2):e2277. PubMed ID: 34286893
[TBL] [Abstract][Full Text] [Related]
99. Neutralizing antibody activity against SARS-CoV-2 variants in gestational age-matched mother-infant dyads after infection or vaccination.
Matsui Y; Li L; Prahl M; Cassidy AG; Ozarslan N; Golan Y; Gonzalez VJ; Lin CY; Jigmeddagva U; Chidboy MA; Montano M; Taha TY; Khalid MM; Sreekumar B; Hayashi JM; Chen PY; Kumar GR; Warrier L; Wu AH; Song D; Jegatheesan P; Rai DS; Govindaswami B; Needens J; Rincon M; Myatt L; Asiodu IV; Flaherman VJ; Afshar Y; Jacoby VL; Murtha AP; Robinson JF; Ott M; Greene WC; Gaw SL
JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35579965
[TBL] [Abstract][Full Text] [Related]
100. Delta variant neutralizing antibody response following maternal COVID-19 vaccination.
Craig AM; Pavon CG; Byrd A; Weaver K; Swamy GK; Fouda G; Hughes BL
Am J Infect Control; 2024 Feb; 52(2):252-254. PubMed ID: 37689124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
